Doesn't make for pretty reading. The sales growth is off a lower base, so if you annualise it from 2019 pre-Covid it's around 5% yoy. It's not clear from the results how much of it is related to amgen replacements, but I think that's something to look out for. With regards to the margins, well -12% to 53% is pretty poor. In the annual report they had -11% to 62% due to freight. Extrapolating that out, it's a further -9% due to product and geographic mix.
It will be important to determine how much of this is temporary due to Covid vs how much is permanent due to the product/geographic mix. If margin compression is occurring faster than sales growth, then that's something for investors to worry about - at this stage, that doesn't seem certain to me.
Doesn't make for pretty reading. The sales growth is off a lower...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SDI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
78.5¢ |
Change
0.005(0.64%) |
Mkt cap ! $93.30M | |||
| Open | High | Low | Value | Volume |
| 78.5¢ | 78.5¢ | 78.5¢ | $1.818K | 2.316K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 18389 | 78.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 79.0¢ | 12556 | 1 |
View Market Depth
| Last trade - 13.26pm 28/06/2024 (20 minute delay) ? |
| SDI (ASX) Chart |